Metabolic aspects of the comutagenic action of norharman.
D000470:Alkaloids / Q000378:metabolism*; D000631:Aminopyridines / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001711:Biotransformation; D002243:Carbolines; D006247:Harmine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D008862:Microsomes, Liver / Q000378:metabolism; D009152:Mutagenicity Tests; D009153:Mutagens / Q000494:pharmacology; D009154:Mutation; D012486:Salmonella typhimurium / Q000187:drug effects; D013329:Structure-Activity Relationship; D014052:Toluidines / Q000494:pharmacology
D000470:Alkaloids; D000631:Aminopyridines; D000814:Aniline Compounds; D002243:Carbolines; D009153:Mutagens; D014052:Toluidines; D006247:Harmine; C010262:norharman